Digibind attenuates cytokine TNFα-induced endothelial inflammatory response: Potential benefit role of Digibind in preeclampsia

Journal of Perinatology

Volumn 29, Issue 3, 2009, Pages 195-200

  Wang, Y ^a   Lewis, D F ^a   Adair, C D ^b   Gu, Y ^a   Mason, L ^b   Kipikasa, J H ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) BETA1; DIGOXIN ANTIBODY F(AB) FRAGMENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN ANTIBODY REACTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOASSAY; INFLAMMATION; PREECLAMPSIA; PROTEIN EXPRESSION; UPREGULATION;

CELL ADHESION MOLECULES; CELLS, CULTURED; COHORT STUDIES; DIGOXIN; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOLOGIC FACTORS; PRE-ECLAMPSIA; PREGNANCY; SODIUM-POTASSIUM-EXCHANGING ATPASE; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL VEINS;

EID: 61849161170     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.222     Document Type: Article

References (20)

1. Graves SW, Williams GH. An endogenous ouabain-like factor associated with hypertensive pregnant women. J Clin Endocrinol Metabol 1984; 59: 1070-1074.
2. Lopatin DA, Ailamazian EK, Dmitrieva RI, Shpen VM, Fedorova OV, Doris PA et al. Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsia. J Hypertens 1999; 17: 1179-1187.
3. Averina IV, Tapilskaya NI, Reznik VA, Frolova EV, Fedorova OV, Lakatta EG et al. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia. Cell Mol Biol (Noisy-le-grand) 2006; 52: 19-23.
4. Roberts JM, Taylor RN, Musci TJ, Rodgers GM, Hubel CA, McLaughlin MK. Preeclampsia: An endothelial cell disorder. Am J Obstet Gynecol 1989; 161: 1200-1204.
5. Redman CWG, Sacks GP, Sargent IL. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499-506.
6. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-a is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994; 170: 1752-1759.
7. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Bri J Obstet Gynecol 1995; 102: 20-25.
8. Lyall F, Greer IA, Boswell F, Macara LM, Walker JJ, Kingdom JCP. The cell adhesion molecule, VCAM-1, is selectively elevated in serum in pre-eclampsia: Does this indicate the mechanism of leucocyte activation? Br J Obstet Gynaecol 1994; 101: 485-487.
9. Chaiworapongsa T, Romero R, Yoshimatsu J, Espinoza J, Kim YM, Park K et al. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia. J Matern Fetal Neonatal Med 2002; 12: 19-27.
10. Adair CD, Buckalew V, Taylor K, Ernest JM, Frye AH, Evans C et al. Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: Treatment with digoxin-binding immunoglobulin. Am J Nephrol 1996; 16: 529-531.
11. Adair CD, Hinshaw H, Russell G, Rose J, Veille J, Buckalew V. Effects of digoxin specific-antibody on mean arterial pressure in severe preeclampsia. Presented at the 12th Scientific Meeting of the American Society of Hypertension, San Francisco, CA, May 29, 1997.
12. Wang Y, Adair CD, Coe L, Weeks JW, Lewis DF, Alexander JS. Activation of endothelial cells in preeclampsia: Increased neutrophil-endothelial adhesion correlates with upregulation of adhesion molecule P-selectin in human umbilical vein endothelial cells isolated from preeclampsia. J Soc Gynecol Investig 1998; 5: 237-243.
13. Canzoneri BJ, Lewis DF, Zhang Y, Gu Y, Philibert L, Groome LJ et al. Maternal circulating TNFa levels are highly correlated with IL-10 levels, but not IL-6 and IL-8 levels, in women with preeclampsia. Am J Obstet Gynecol 2006; 193(6).
14. Ohno N, Ichikawa H, Coe L, Kvietys PR, Granger DN, Alexander JS. Soluble selectins and ICAM-1 modulate neutrophil-endothelial adhesion and diapedesis in vitro. Inflammation 1997; 21: 313-324.
15. Silber A, Newman W, Reimann KA, Hendricks E, Walsh D, Ringler DJ. Kinetic expression of endothelial adhesion molecules and relationship to leukocyte recruitment in two cutaneous models of inflammation. Lab Invest 1994; 70: 163-175.
16. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML. Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88: 420-427.
17. Lam G, Johnson D, Robinson C, Saade G, Lewis DF, Porter K et al. Antepartum administration of a Digoxin immune fab (Digibind) improves renal function in patients with severe preeclampsia. Presented at the XVI World Congress of International Society for the Study of Hypertension in Pregnancy, 2008; Washington, DC, USA, Sept. 20-24, 2008, pp. 1-2.
18. Hopate M, Graves S, Adair CD, Lam G, Johnson D, Saade G et al. In-vivo reversal of functional sodium pump inhibition with Digibind Treatment. Presented at the XVI World Congress of International Society for the Study of Hypertension in Pregnancy, 2008; Washington, DC, USA, Sept. 20-24, 2008.
19. Kaplan JH. Biochemistry of Na,K-ATPase. Annu Rev Biochem 2002; 71: 511-535.
20. Eakle KA, Kabalin MA, Wang SG, Farley RA. The influence of beta subunit structure on the stability of Na+/K(+)-ATPase complexes and interaction with K+. J Biol Chem 1994; 269: 6550-6557.